Detalles de la búsqueda
1.
Physiologically Based Pharmacokinetic Modeling of Vitamin D3 and Metabolites in Vitamin D-Insufficient Patients.
Drug Metab Dispos
; 50(9): 1161-1169, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779863
2.
Regulation of renal calbindin expression during cisplatin-induced kidney injury.
J Biochem Mol Toxicol
; 36(7): e23068, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403300
3.
Influence of vitamin D treatment on functional expression of drug disposition pathways in human kidney proximal tubule cells during simulated uremia.
Xenobiotica
; 51(6): 657-667, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870862
4.
In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
Int J Mol Sci
; 22(12)2021 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34208557
5.
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury.
Int J Mol Sci
; 22(6)2021 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33801801
6.
Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy.
Ann Pharmacother
; 53(4): 357-363, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293439
7.
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients.
Eur J Clin Pharmacol
; 75(1): 51-57, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30220072
8.
Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac Surgery.
Ther Drug Monit
; 40(2): 186-194, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29529007
9.
In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.
Pharm Res
; 34(8): 1637-1647, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28405913
10.
Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Int J Mol Sci
; 18(7)2017 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28640195
11.
Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review.
J Cardiovasc Pharmacol
; 67(2): 175-81, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26448275
12.
Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.
Drug Metab Dispos
; 43(4): 611-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25650382
13.
Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.
J Biochem Mol Toxicol
; 29(6): 261-6, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25683455
14.
A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis.
Int J Clin Pharmacol Ther
; 52(4): 303-13, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24548980
15.
Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studies.
J Pharm Biomed Anal
; 245: 116179, 2024 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38703749
16.
Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.
Pharmacogenet Genomics
; 23(12): 684-96, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24128937
17.
Impact of severe hypothyroidism on cyclophosphamide disposition and routes of metabolism and transport in a patient with treatment-resistant lupus nephritis.
Ann Pharmacother
; 47(7-8): e35, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23737517
18.
Clinical Characteristics and Outcomes of Drug-Induced Acute Kidney Injury Cases.
Kidney Int Rep
; 8(11): 2333-2344, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025217
19.
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.
Br J Clin Pharmacol
; 74(3): 445-55, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22380717
20.
Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption.
Curr Opin Toxicol
; 312022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36777447